Media-OutReach Newswire Sapu Nano Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway
Media-OutReach Newswire Nano Singapore Expands Premium Supplement Range in Malaysia to Meet Growing Demand for Science-Backed Wellness